From: Immunoreactivity to metal and silica associates with sarcoidosis in Dutch patients
LPT-negative (%) (n = 26) | LPT-positive (%) (n = 7) | P* | |
---|---|---|---|
Male / Female | 92.3 / 7.7 | 85.7/ 14.3 | 0.52 |
Age at diagnosis (Y) | 43.46 ± 11.61 | 41.40 ± 7.97 | 0.66 |
Time after diagnosis (Y) | 13.65 ± 12.39 | 9.21 ± 8.21 | 0.36 |
Medication | 46.2 | 42.9 | 1.00 |
Scadding stage at diagnosis (0/I/II/III/IV, unknown) | 11.5/26.9/42.3/3.8/0/ 15.4 | 0/42.9/28.6/0/14.3/ 14.3 | 0.36 |
Scadding stage at inclusion (0/I/II/III/IV, unknown) | 38.5/7.7/11.5/11.5/30.8/ 0 | 28.6/14.3/14.3/0/28.6/ 14.3 | 0.42 |
Extra pulmonary involvement | 57.7 | 57.1 | 1.00 |
COS | n = 21 | n = 5 | |
Resolved & minimal disease | 4.8 | 40 | 0.09 |
Persistent disease without therapy | 33.3 | 20 | 1.00 |
Persistent disease with need for therapy | 61.9 | 40 | 0.62 |